After Hours Gainer
CASI Casi Pharmaceuticals -3.59-0.03-1.0%
After Hours:5.87+2.28 (+63.7%)
CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company
PRNewswireWed, 26-Jun 4:15 PM
CASI Casi Pharmaceuticals -3.57-0.05-1.4%
After Hours:5.63+2.06 (+57.7%)